SCM
BMY icon

Smead Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Smead Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-193,483
Closed -$10.3M – 29
2013
Q4 		$10.3M Sell
193,483
-105,341
-35% -$5.37M 1.42% 28
2013
Q3 		$13.8M Buy
298,824
+47,261
+19% +$2.07M 2.24% 23
2013
Q2 		$11.2M Buy
+251,563
New +$10.9M 2.28% 23

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Smead Capital Management's BMY Position: Q1 2014 in Review

Smead Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2014, closing a stake of 193,483 shares — an estimated $10.3M sold.

Smead Capital Management first reported a position in BMY in Q2 2013 and held it in 3 quarters. The position peaked at $13.8M in Q3 2013. 1,328 funds tracked by Wall St. Rank hold BMY as of Q1 2014.

  • Smead Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2014 after selling out during the quarter.
  • Smead Capital Management sold 193,483 Bristol-Myers Squibb shares in Q1 2014, an estimated $10.3M.
  • Smead Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 3 quarters.
  • Smead Capital Management's Bristol-Myers Squibb position peaked at $13.8M in Q3 2013.
  • 1,328 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2014.

Based on Smead Capital Management's 13F filing for Q1 2014, filed 8 May 2014.